artbio.com
Get leads like Artbio — and thousands more
Build targeted lists by tech stack, traffic, and more
ARTBIO: The Alpha Radioligand Disruptor
How a lean biotech is quietly redefining cancer care with alpha particles
ARTBIO isn't just another cancer biotech—it's a precision strike force targeting tumors with alpha particles, the most powerful form of radiation. With a lean team of 81 and $113M in funding, they're building an ecosystem that could make traditional chemo look obsolete.
"They're not just developing therapies—they're building a manufacturing moat while competitors are still figuring out clinical trials."
The Alpha Advantage
ARTBIO's alpha radioligand therapies deliver cell-killing radiation with surgical precision. Unlike beta emitters or external beam radiation, alpha particles travel just a few cell diameters but pack 1000x more energy. This means maximum tumor destruction with minimal collateral damage—a game-changer for hard-to-treat cancers. Their approach treats radioligand therapy as a platform, not a one-off drug.
Ecosystem Over Product
While most biotechs focus purely on drug development, ARTBIO is vertically integrating with manufacturing capabilities. Their $12.6M revenue (likely from early-stage collaborations and manufacturing services) suggests they're already generating cash flow while developing their pipeline. This is rare for pre-revenue biotechs and signals strategic foresight—owning the supply chain means controlling destiny in a space plagued by manufacturing bottlenecks.
The search data reveals telling patterns: 'radioligand manufacturing startup' and 'SpectronRx' appear as top keywords. This suggests ARTBIO is positioning itself as a manufacturing partner, not just a drug developer. Their traffic is 49% direct—strong brand recall for a company with under 5K monthly visitors—indicating they're on the radar of investors, partners, and industry insiders.
- Lean execution: 81 employees with $113M funding (1.4x capital efficiency vs. biotech average)
- Early revenue generation: $12.6M suggests active partnerships or manufacturing services
- Vertical integration: Building manufacturing capability while developing therapies
- Strategic keyword targeting: Capturing manufacturing-related searches, not just clinical ones
The Quiet Disruptor
ARTBIO isn't betting on hype—they're building the infrastructure for alpha therapy dominance while others chase beta emitters. Their $12.6M in revenue with 81 employees shows they're executing, not just fundraising. In a field where manufacturing is the bottleneck, owning that piece could be their ultimate moat.
What tech stack does Artbio use?
How much traffic does Artbio get?
Traffic & Engagement
Traffic Sources
Where is Artbio's audience located?
What keywords does Artbio rank for?
5 keywordsHow is Artbio's SEO?
Meta Tags
ARTBIO
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.
H1 Tags
What is Artbio's revenue?
Who works at Artbio?
Loading leads...
What do customers think of Artbio?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Artbio
What is Artbio's Revenue?
What does Artbio do?
How fast is Artbio growing?
What technologies does Artbio use?
Who are Artbio's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Artbio?
Contact Information
Export artbio.com Data
Download the complete tech stack, analytics, leads, and company data for artbio.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About artbio.com
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.
Company Overview
artbio.com Social Media
Contact artbio.com
Email Addresses
Phone Numbers
Technology Stack
artbio.com uses 11 technologies across their website including HSTS, Netlify, Google Tag Manager, Google Analytics, and more.
Security
HSTS
Cloud & Hosting
Netlify
Analytics & Marketing
Google Tag Manager, Google Analytics
Performance
Lazy Loading
Web Standards
Twitter Cards, PWA
UI Libraries
DaisyUI
Traffic & Audience
artbio.com receives approximately 4.4K monthly visitors and ranks #4,067,395 globally. The website has a bounce rate of 35% with visitors viewing an average of 1.7 pages per visit. Users spend an average of 0:10 on the site.
The majority of artbio.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is artbio.com?
What technologies does artbio.com use?
How do I contact artbio.com?
What are artbio.com's social media accounts?
Is artbio.com hiring?
How popular is artbio.com?
Related Searches
This page provides publicly available information about artbio.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit artbio.com directly at https://artbio.com.